Inventor · disambiguated record
Srinivasa Karra
Also filed as: KARRA SRINIVASA · KARRA SRINIVASA R · KARRA SRINIVASA RAO
38 granted patents·10 pending applications·140 citations·filing 1997–2025
97Inventor score
Files withMERCK PATENT GMBH14AVILAR THERAPEUTICS INC11ALKERMES INC7GOUTOPOULOS ANDREAS2HUCK BAYARD R2
Top patents by PatentIndex Score
48 records- 0196US11819551B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2022·Granted Nov 21, 2023·10 cites·30 claims
- 0291US12006330B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Jun 11, 2024·2 cites·113 claims
- 0391US8815872B2Macrocyclics pyrimidines as aurora kinase inhibitorsYU HENRY·Filed 2009·Granted Aug 26, 2014·24 cites·5 claims
- 0491US8076486B2Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitorsGOUTOPOULOS ANDREAS·Filed 2007·Granted Dec 13, 2011·25 cites·21 claims
- 0590US12054495B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2022·Granted Aug 6, 2024·1 cites·51 claims
- 0689US12290568B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·1 cites·30 claims
- 0789US12280116B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted Apr 22, 2025·1 cites·30 claims
- 0888US12128106B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted Oct 29, 2024·1 cites·5 claims
- 0988US11760747B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Sep 19, 2023·1 cites·121 claims
- 1088US9399623B2Quinoline derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2015·Granted Jul 26, 2016·6 cites·17 claims
- 1186US12312340B2Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted May 27, 2025·0 cites·11 claims
- 1284US11542276B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2020·Granted Jan 3, 2023·1 cites·122 claims
- 1384US9931324B2Indolizine derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2016·Granted Apr 3, 2018·4 cites·16 claims
- 1484US7276531B2G-lactam derivatives as prostaglandin agonistsAPPLIED RESEARCH SYSTEMS·Filed 2004·Granted Oct 2, 2007·20 cites·31 claims
- 1583US11440899B2Pyrimidine TBK/IKKe inhibitor compounds and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Sep 13, 2022·3 cites·19 claims
- 1683US8569295B2Bicyclic urea compoundsCHEN XIAOLING·Filed 2010·Granted Oct 29, 2013·8 cites·60 claims
- 1783US2025339541A1Asgpr-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1882US12091402B2Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1982US8637532B2Amino azaheterocyclic carboxamidesSUTTON AMANDA E·Filed 2010·Granted Jan 28, 2014·9 cites·10 claims
- 2081US2025213699A1Asgpr-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2180US9139568B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2012·Granted Sep 22, 2015·4 cites·13 claims
- 2279US2025092063A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2378US12441710B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2023·Granted Oct 14, 2025·0 cites·47 claims
- 2476US2025223280A1Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2575US10428080B2TBK/IKK inhibitor compounds and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Oct 1, 2019·1 cites·20 claims
- 2674US9040560B2Amino azaheterocyclic carboxamidesMERCK PATENT GMBH·Filed 2013·Granted May 26, 2015·2 cites·9 claims
- 2774US2024368182A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2873US12076408B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·26 claims
- 2973US10323000B2Indole derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2015·Granted Jun 18, 2019·1 cites·7 claims
- 3072US9988391B2TBK/IKK inhibitor compounds and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Jun 5, 2018·1 cites·11 claims
- 3172US7772233B2Arylamino N-heteroaryl compounds as MEK inhibitorsMERCK SERONO SA·Filed 2007·Granted Aug 10, 2010·1 cites·13 claims
- 3272US6458816B1Modified prodrug forms of AP/AMPVION PHARMACEUTICALS INC·Filed 2001·Granted Oct 1, 2002·6 cites·59 claims
- 3368US8735584B2Protein kinase inhibitors and use thereofHUCK BAYARD R·Filed 2009·Granted May 27, 2014·1 cites·2 claims
- 3467US8802703B2Arylamino N-heteraryl compounds as MEK inhibitorsGOUTOPOULOS ANDREAS·Filed 2010·Granted Aug 12, 2014·1 cites·1 claims
- 3566US8710044B2Bicyclic azaheterocyclic carboxamidesHUCK BAYARD R·Filed 2011·Granted Apr 29, 2014·1 cites·9 claims
- 3665US10676433B2Indole derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2019·Granted Jun 9, 2020·0 cites·11 claims
- 3765US2024239828A1Mannose 6-phosphate or asgpr receptor binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3860US9249114B2Thiazole derivativesKARRA SRINIVASA R·Filed 2012·Granted Feb 2, 2016·1 cites·14 claims
- 3952US10080753B2Heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2016·Granted Sep 25, 2018·0 cites·5 claims
- 4052US2011269758A1Naphthyridinones as protein kinase inhibitorsMERCK PATENT GMBH·Filed 2009·Application pending·0 cites
- 4147US9938268B2C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereofXIAO YUFANG·Filed 2009·Granted Apr 10, 2018·0 cites·2 claims
- 4247US2016058763A1Novel heterocyclic carboxamides as modulators of kinase activityMERCK PATENT GMBH·Filed 2015·Application pending·0 cites
- 4345US9546166B2Indolizine derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2015·Granted Jan 17, 2017·0 cites·16 claims
- 4441US9273029B2Pyridine-and pyrazine derivativesHOELZEMANN GUENTER·Filed 2012·Granted Mar 1, 2016·0 cites·36 claims
- 4541US2016296509A1Novel quinoline derivatives and their use in neurodegenerative diseasesMERCK PATENT GMBH·Filed 2016·Application pending·0 cites
- 4638US5855867AHydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making sameUNIV MISSOURI·Filed 1997·Granted Jan 5, 1999·3 cites·19 claims
- 4737US2023019491A1PYRIMIDINE TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOFKARRA SRINIVASA R·Filed 2018·Application pending·0 cites
- 4829US6054115AHydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making sameUNIV MISSOURI·Filed 1998·Granted Apr 25, 2000·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Srinivasa Karra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →